Skip to main content
. 2019 Mar 5;12(5):756. doi: 10.3390/ma12050756

Figure 8.

Figure 8

(a) Viability of LNCaP and PC3 cells after exposure to doxorubicin-Plain-liposome, doxorubicin-P3-liposomes, free doxorubicin, and empty liposomes for 24 h. (b,c) Viability vs. exposure time plots for LNCaP and PC3 cells, respectively, exposed to doxorubicin-Plain-liposome, doxorubicin-P3-liposomes, and free doxorubicin ((doxorubicin) = 1 µM, * p < 0.05, ** p < 0.01).